Tau Protein, beta-Amyloid 1-42 and Clusterin CSF Levels in Differential Diagnosis of Parkinsonian Syndrome with Dementia

被引：0
|
作者：
Vranova, Hana Prikrylova [1 ,2 ]
Henykova, Eva [3 ]
Kaiserova, Michaela [1 ,2 ]
Mensikova, Katerina [1 ,2 ]
Vastik, Miroslav [1 ,2 ]
Mares, Jan [1 ,2 ]
Hlustik, Petr [1 ,2 ]
Zapletalova, Jana [4 ]
Strnad, Miroslav [3 ]
Stejskal, David [5 ]
Kanovsk, Petr [1 ,2 ]
机构：
[1] Palacky Univ, Sch Med, Dept Neurol, CR-77147 Olomouc, Czech Republic
[2] Univ Hosp, Olomouc, Czech Republic
[3] Palacky Univ, Fac Sci, Lab Growth Regulator, CR-77147 Olomouc, Czech Republic
[4] Palacky Univ, Fac Med & Dent, Dept Med Biophys, CR-77147 Olomouc, Czech Republic
[5] Palacky Univ, Dept Biochem Med & Dent, CR-77147 Olomouc, Czech Republic
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P04156
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tau protein, beta-amyloid1-42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
    Vranova, Hana Prikrylova
    Henykova, Eva
    Kaiserova, Michaela
    Mensikova, Katerina
    Vastik, Miroslav
    Mares, Jan
    Hlustik, Petr
    Zapletalova, Jana
    Strnad, Miroslav
    Stejskal, David
    Kanovsky, Petr
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 343 (1-2) : 120 - 124
  • [2] CSF levels of β-amyloid 1-42, tau and phosphorylated tau protein in CADASIL
    Formichi, P.
    Parnetti, L.
    Radi, E.
    Cevenini, G.
    Dotti, M. T.
    Federico, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (11) : 1252 - 1255
  • [3] Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42)
    Kaiser, Elmar
    Schoenknecht, Peter
    Thomann, Philipp A.
    Hunt, Aoife
    Schroeder, Johannes
    [J]. NEUROSCIENCE LETTERS, 2007, 417 (02) : 193 - 195
  • [4] Plasma levels of beta-amyloid (1-42) in fronto-temporal dementia
    Lovati, C.
    Bertora, P.
    Pesaresi, M.
    Galimberti, D.
    Venturelli, E.
    Mailland, E.
    Rosa, S.
    Clerici, F.
    Pomati, S.
    Scarpini, E.
    Forloni, G.
    Mariani, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 68 - 69
  • [5] Significance of CSF levels of tau protein and β42-amyloid for diagnosis and differential diagnosis of dementia diseases in a specialized geriatric hospital
    Nehen, H. G.
    Honneth, J.
    Haseke, J.
    Fahnenstich, H.
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2009, 42 (05): : 391 - 393
  • [6] Tau polymorphisms and CSF beta-amyloid effect on CSF tau and phosphotau levels in Parkinson's disease dementia
    Compta, Y.
    Ezquerra, M.
    Marti, M. J.
    Munoz, E.
    Valldeoriola, F.
    Tolosa, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 527 - 527
  • [7] Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein
    Manassero, Giusi
    Guglielmotto, Michela
    Zamfir, Raluca
    Borghi, Roberta
    Colombo, Laura
    Salmona, Mario
    Perry, George
    Odetti, Patrizio
    Arancio, Ottavio
    Tamagno, Elena
    Tabaton, Massimo
    [J]. AGING CELL, 2016, 15 (05): : 914 - 923
  • [8] Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein
    Marksteiner, Josef
    Hinterhuber, Hartmann
    Humpel, Christian
    [J]. DRUGS OF TODAY, 2007, 43 (06) : 423 - 431
  • [9] Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein
    Manassero, G.
    Guglielmotto, M.
    Borghi, R.
    Perry, G.
    Odetti, P.
    Arancio, O.
    Tamagno, E.
    Tabaton, M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 : S77 - S77
  • [10] Proportion of tau protein to phosphorylated tau protein CSF levels in differential diagnosis of dementia
    Hort, J.
    Valis, M.
    Waberzinek, G.
    Talab, R.
    Glossova, L.
    Bojar, M.
    Vyhnalek, M.
    Skoda, D.
    Masopust, J.
    Stourac, P.
    [J]. NERVENARZT, 2008, 79 (08): : 891 - +
12345